ARCHIVES

Nexavar Improves PFS In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

ECOG Subcontractors Critique Cancer Control Program

August 24, 1979

NCI TO Issue RFA For Gene Therapy Studies; $20 Mil. Se-Aside Ok’d

January 10, 1992

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996

NCCS Plans Rays Of Hope Event At Ellipse On Sept. 15.

July 27, 2001

VTP Implementing 95% Of Ad Hoc Panel Suggestions

May 10, 1985

Power’s Offer to Write Report On NCAB’s Organ Systems Decision Declined By DeVita

June 15, 1984